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The metastatic spread of cancer cells is a step-wise process that starts with dissociation from primary
tumours and local invasion of adjacent tissues. The ability to invade local tissues is the product of several
processes, including degradation of extracellular matrices (ECM) and movement of tumour cells through
physically-restricting gaps. To identify properties contributing to tumour cells squeezing through narrow
gaps, invasive MDA-MB-231 human breast cancer and MDA-MB-435 human melanoma cells were
subjected to three successive rounds of selection using cell culture inserts with highly constraining 3 μm
pores. For comparison purposes, flow cytometry was also employed to enrich for small diameter MDA-
MB-231 cells. RNA-Sequencing (RNA-seq) using the Illumina NextSeq 500 platform was undertaken to
characterize how gene expression differed between parental, invasive pore selected or small diameter cells.
Gene expression results obtained by RNA-seq were validated by comparing with RT-qPCR. Transcriptomic
data generated could be used to determine how alterations that enable cell passage through narrow spaces
contribute to local invasion and metastasis.
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Background & Summary
The metastatic spread of cancer cells from primary tumours to distant sites is the most serious and
deadliest aspect of the disease, with estimates of up to 90% of cancer related deaths being directly
associated with metastasis1,2. In addition, it has become apparent that the same processes that contribute
to cancer metastasis also facilitate primary tumour growth3,4. As a result, characterizing the properties of
metastatic cells that enable their dissemination may identify actionable targets for chemotherapy that
could reduce cancer spread and possibly tumour growth and progression.
The metastatic ability of cancer cells results from several changes in their normal behaviours5. The
strength of cell-cell adhesions is often lessened, allowing individual or groups of cells to separate and
move away from the primary tumour6. The movement away from the tumour into adjacent tissue may be
promoted by changes in migratory behaviour, increased extracellular matrix (ECM) degrading activity,
and the ability to squeeze between cells and ECM protein fibres7. In the next stage, locally invasive cells
may spread further by moving through surfaces surrounding body cavities, via lymphatic or blood vessels,
or through canalicular spaces. Ultimately, tumour cells may move to a secondary site, the location of
which may be influenced by variables including the route taken, intrinsic properties of the target tissue,
and accessibility to factors, such as tumour cell-generated exosomes, that condition a pre-metastatic
niche. Common to several stages of the metastatic process is the ability of tumour cells to squeeze
through narrow spaces. As a result, it can be predicted that changes in the deformability of tumour cells
that enabled their movement through physically constraining conditions in their three dimensional
environment would likely promote cancer spread8.
To select for cells that were better able to move through narrow gaps, MDA-MB-231 D3H2LN human
breast cancer cells expressing firefly luciferase (Luc)9 (abbreviated MDA-MB-231) and MDA-MB-435
human melanoma cells (which were mistakenly used in the past as a breast cancer model until its cancer
type was corrected)10 were subjected to three rounds of enrichment using tissue culture inserts with 3 μm
pores (Fig. 1a). By plating cells on microporous membranes in serum-free medium in the inserts,
and then transferring the inserts to tissue cultures dishes containing medium supplemented with 10%
fetal bovine serum (FBS), a chemotactic gradient was created to attract cells to move through the
restricting narrow pores. Several independent ‘Selected’ populations of cells were established from both
MDA-MB-231 and MDA-MB-435 cells in this manner. Given the possibility that selection through
narrow pores would enrich for small cells, several independent ‘FlowSorted’ populations of small
diameter MDA-MB-231 cells were also selected by three consecutive rounds of flow cytometry (Fig. 1b).
Parental, Selected and FlowSorted populations of MDA-MB-231 and MDA-MB-435 cells were fixed
and stained with phalloidin to reveal filamentous actin (F-actin) structures and cell morphology. Selected
and FlowSorted MDA-MB-231 cells, as well as Selected MDA-MB-435 cells, were notably smaller than
their originating parental cells (Fig. 1c). In addition, Selected cells from both tumour cell lines were
marked by fewer cytoplasmic and cortical distinct F- actin fibres, more actin-rich protrusive regions
(indicated by white arrows), and more irregular circumferential membranes compared to their respective
parents (Fig. 1c). When invasion into three dimensional fibroblast-conditioned dense collagen matrices
was examined, Selected MDA-MB-231cells were markedly more invasive than Parental or FlowSorted
cells (Fig. 1d). In addition, pore-selection changed relatively non-invasive Parental MDA-MB-435 cells
into highly invasive Selected cells (Fig. 1d).
To determine how gene expression differs between Parental, Selected and FlowSorted populations of
MDA-MB-231 and MDA-MB-435, total RNA was extracted and enriched for polyA+ mRNAs, and then
subjected to RNA-Sequencing (Fig. 2 and Table 1). The study has been described at the NCBI Bioproject
(PRJNA327913), with descriptions of the MDA-MB-231 cells (SAMN07311741) and MDA-MB-435 cells
(SAMN07311743). Primary data are available at the NCBI Sequence Read Archive (Table 2 (available
online only) and Data Citation 1). The transcriptomic data generated by this study may reveal important
modifiers of the physical properties that enable tumour cells to move through narrow spaces, as well as
regulators of cell size, that contribute to the metastatic spread of cancer.
Methods
Cell culture
Human MDA-MB-231 D3H2LN Luc9 (abbreviated MDA-MB-231) breast cancer cells (Caliper
LifeScience, Hopkinton MA USA) and MDA-MB-435 melanoma cells (ATCC, Teddington UK) were
grown in Hyclone MEM/EBSS media, supplemented with 10% fetal bovine serum (FBS), 2 mM
L-glutamine, 10 U/ml penicillin and 10 μgml−1 streptomycin, 1% MEM/NEAA (non-essential amino
acid), 1% Sodium Pyruvate (all Gibco, Fisher Scientific, Loughborough, UK) at 37 °C with 5% CO2 in a
humidified incubator. Cell line identities were validated by the Cancer Research UK Beatson Institute
Molecular Services using the GenePrint 10 system STR multiplex assay (Promega, Southampton UK) that
amplifies 9 tetranucleotide repeat loci and Amelogenin gender determining marker.
Cell line selection
Independent MDA-MB-231 or MDA-MB-435 pore-selected (Selected) cell populations were established
by seeding 1 × 106 cells in 10 ml serum-free medium on 3 μm pore membranes in 7.5 cm cell culture
inserts (Corning, Fisher Scientific, Loughborough, UK). Inserts were placed in 10 cm dishes containing
10 ml serum-containing medium, and left for four days in standard tissue culture conditions to allow cells
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Figure 1. Selection strategies to enrich for invasive or small diameter cells. (a) MDA-MB-231 or
MDA-MB-435 cells were plated in serum-free medium into tissue culture inserts with 3 μm pores, and placed
in tissue culture dishes containing medium with 10% fetal bovine serum (FBS). Cells able to migrate through
pores and attach to the underlying dishes were expanded, re-plated and the selection repeated twice more. At
the end, several independent Selected cell populations were established. (b) MDA-MB-231 cells were sorted by
flow cytometry (side scatter and forward scatter) and gated in the P1 region (red) for small diameter cells. After
two additional rounds of expansion and sorting, several independent FlowSorted populations were established.
(c) Representative Parental, Selected and FlowSorted MDA-MB-231 cells, as well as Parental and Selected
MDA-MB-435 cells, were fixed, stained with Alexa Fluor488-conjugated phalloidin to enable visualization of
filamentous actin structures. Actin-rich protrusive regions have been indicated for Selected cells with white
arrows. Scale bars= 10 μm. (d) H&E‐stained sections of cell invasion into collagen matrix after 8 days. Scale
bar= 100 μm.
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to migrate through the pores. The inserts were then removed, media was changed and plates were placed
back in the incubator to expand the selected cell population. The selection process was repeated twice
more as described above.
Independent small diameter MDA-MB-231 flow cytometry sorted (FlowSorted) populations were
obtained by gating on cells with low forward scatter and side scatter parameters as indicated in the red
region in Fig. 1b using a FACSAria Fusion sorter (BD Biosciences, Oxford UK). FlowSorted cells were
then grown using standard tissue culture conditions to expand the isolated sorted cell populations,
followed by two additional rounds of sorting as described above.
Cells were stained and imaged as described in ref. 11. For filamentous actin imaging, 0.8 × 105 cells
were seeded on 13 mm autoclaved cover slips and grown overnight. Cells were washed with phosphate
buffered saline (PBS), then fixed with 4% paraformaldehyde/PBS solution, permeabilized with 0.5% (v/v)
Triton X-100/PBS, blocked with 1% (w/v) bovine serine albumin (Sigma-Aldrich, Gillingham, UK)/PBS,
and then incubated with Alexa Fluor488 phalloidin (Sigma-Aldrich, Gillingham, UK) (1:1,000 dilution)
for 1 h at room temperature. Cover slips were washed twice with PBS and inverted on 7 μl of ProLong
Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific, Renfrew UK) on a glass slide. Cells
were imaged on a Zeiss 880 confocal microscope (Cambridge UK) using a 63X oil objective.
Collagen matrix invasion assays were performed as previously described11. Primary human fibroblasts
were mixed with rat tail collagen1 and placed in a cell culture incubator for a week to allow conditioning
of the collagen. To remove fibroblasts from the collagen matrices, the disks were incubated with 5 μgml−1
Puromycin for at least 24 h and then washed twice with medium. 2 × 105 cells were seeded on top of the
disks and allowed to settle and grow over 2 days. Afterward, the collagen matrices were mounted onto
grids to generate an air/liquid interface. After 8 days, the collagen disks were fixed in 4%
paraformaldehyde overnight and processed using standard histological methods. H&E‐stained sections
were scanned and analyzed using Digital Slide Server (SlidePath, Leica, Milton Keynes UK) software.
Cell line BioSample Cell
population
Enrichment method Biological
replicates
Protocol 1 Protocol 2
MDA-MB-231 D3H2LN Luc SAMN07311741 Parental None 4 RNA extraction RNA-Seq
MDA-MB-231 D3H2LN Luc SAMN07311741 Selected Selection through 3 μm pores 3 RNA extraction RNA-Seq
MDA-MB-231 D3H2LN Luc SAMN07311741 FlowSorted Selection for small diameter by flow
cytometry
3 RNA extraction RNA-Seq
MDA-MB-435 SAMN07311743 Parental None 4 RNA extraction RNA-Seq
MDA-MB-435 SAMN07311743 Selected Selection through 3 μm pores 4 RNA extraction RNA-Seq
Table 1. Experimental samples and design.
MDA MB 231 breast cancer and MDA MB 435 melanoma cell lines
Total RNA extraction
RT-qPCR analysisIllumina sequencing:
TruSeq mRNA library preparation
NextSeq 500 platform
Collection and initial quality control of raw
RNA-Seq data (fastqc, fastq_screen)
Alignment of RNA-Seq data to human genome and
generation of count data (TopHat2, htseq_count)
Differential analysis of count data (DESeq2)
Principal component analysis
Parental
MDA MB 231 or
MDA MB 435
Selected
MDA MB 231 or
MDA MB 435
Flow Sorted
MDA MB 231
Figure 2. Overview and experimental design of the study.
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RNA isolation
1 × 106 cells were seeded into 6-well plates and allowed to settle and grow overnight. Cells were harvested
with Trypsin and total RNA was extracted using the RNAeasy kit (Qiagen, Manchester UK) according to
manufacturer’s instructions. RNA was quantified using the Nanodrop spectrophotometer (Nanodrop,
Thermo Fisher Scientific, Renfrew UK). The Agilent RNA ScreenTape assay and the Agilent 2,200
TapeStation system (both Agilent, Stockport UK) were used to determine the RNA integrity number
equivalent (RINe; Table 3).
RNA-sequencing
Total RNA was used to generate an oligo dT-enriched library with the Illumina TruSeq RNA Library
Preparation kit v2.0 (Illumina, Cambridge UK). Quality and quantity of the DNA library was assessed
using the Agilent 2,100 Bioanalyzer (Agilent, Stockport UK) and the Qubit (Thermo Fisher Scientific,
Renfrew UK), respectively. The library was run on the Illumina NextSeq 500 platform using the High
Output 75 cycles kit (2 × 36 cycles, paired-end reads, single index) (both Illumina, Cambridge UK).
RNA-sequence analysis
RNA-Sequence analysis and alignment was carried out as described in reference12. Quality control checks
of raw RNA-Seq data files were done with fastqc v0.10.1 (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/) and fastq_screen v0.4.2 (http://www.bioinformatics.babraham.ac.uk/projects/fas-
tq_screen/). RNA-Seq reads were aligned to the human genome build GRCh38 with TopHat2.0.1313
and genome annotation using GRCh38.82.gtf. BAM files were further processed with HTseq0.6.1p1
(http://www.huber.embl.de/users/anders/HTSeq/doc/count.html). Differential analysis of count data was
performed by the DESeq2 package (DESeq2)14. Regularized log transformation was used to transform the
DESeq2 data for principal component analysis.
MDA-MB-231 MDA-MB-435
Sample name RINe Sample name RINe
Parental1 10.0 Parental1 10.0
Parental2 9.9 Parental2 10.0
Parental3 10.0 Parental3 10.0
Parental4 9.9 Parental4 10.0
Selected2-1 10.0 Selected1-1 10.0
Selected2-2 9.9 Selected1-2 10.0
Selected2-3 10.0 Selected1-3 10.0
Selected3-1 10.0 Selected1-4 9.6
Selected3-2 8.9 Selected2-1 10.0
Selected3-3 9.9 Selected2-2 10.0
FlowSorted1-1 10.0 Selected2-3 10.0
FlowSorted1-2 10.0 Selected2-4 10.0
FlowSorted1-3 10.0
FlowSorted2-1 9.9
FlowSorted2-2 10.0
FlowSorted2-3 10.0
Table 3. RNA integrity values for each sample used for RNA sequencing.
Primer target Qiagen catalogue number
LILRB1 QT00024920
TNFSF15 QT00041965
HBEGF QT00000455
PTPRU QT00005677
ENPP1 QT00094787
MXRA8 QT00202790
GAPDH QT00079247
Table 4. PCR primer catalogue numbers.
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Quantitative PCR
Total RNA was used to prepare complementary DNA (cDNA) using a Quantitect Reverse Transcription
kit (Qiagen, Manchester UK). To perform quantitative PCR, the DyNAmo HS SYBR Green qPCR Kit
(Thermo Fisher Scientific, Renfrew UK) was used in triplicate in a 20 μl reaction mixture containing 10 μl
of master mix (master mix contains hot-start polymerase, SYBR green, PCR buffer, 5 mM MgCl2, and
dNTP mix), 6.35 μl of nuclease-free water, 0.15 μl of primer, and 0.4 μl ROX passive reference dye.
Primer catalogue numbers (Qiagen, Manchester UK) are in Table 4. Reaction mixtures were distributed
into MicroAmp Fast Optical 96-well plates and 1.5 μl of cDNA sample or standard added to each well.
The plate was covered with optically transparent sealing film and run on an Applied 7,500 Fast Real-Time
PCR system. A melting curve was performed to validate the presence of single PCR product. Data was
analysed on Applied Biosystem 7,500 Software 2.0.5 and the expression level of genes of interests were
calculated using ΔCt method and normalized to GAPDH.
Data Records
A project overview has been submitted as the BioProject reference PRJNA327913, with descriptions of
the BioSample MDA-MB-231 D3H2LN Luc cells (reference SAMN07311741) and of the BioSample
MDA-MB-435 cells (reference SAMN07311743). Unprocessed RNA-Sequencing reads have been
deposited as fastq files at the National Center for Biotechnology Information (NCBI) Sequence Reads
Archive (SRA) with the reference SRP111915 (Data Citation 1).
The fastq files correspond to four independent biological replicates (BiolRep1–4) for the MDA-
MB-435 melanoma Parental, Selected1 or Selected2 cell populations, or to four independent biological
replicates (BiolRep1–4) for the MDA-MB-231 Parental and three independent biological replicates
(BiolRep1–3) for the Selected2, Selected3, FlowSorted1 or FlowSorted2 cell populations, as indicated in
Table 2 (available online only). For each sequencing reaction run on the Illumina NextSeq 500
instrument, four technical replicates were produced (TechRep1–4). Forward (R1) and reverse (R2) reads
have been combined, with SRA accession numbers for the combined sequencing results also indicated in
Table 2 (available online only). Please also see the associated Metadata Record.
Technical Validation
The quality of extracted RNA (RNA integrity number equivalent; RINe) of all samples was determined
using the Agilent RNA ScreenTape assay and the Agilent 2,200 TapeStation system (Table 3). Following
RNA-seq, correlation coefficients were calculated for all pairwise comparisons of biological replicates
(Table 5), which were ≥ 0.9874292 for MDA-MB-231 cells and ≥ 0.9995527 for MDA-MB-435 cells.
Principal component analysis revealed that the four biological replicates of Parental MDA-MB-231 cells
(Fig. 3a; grey symbols) along with the three biological replicates of FlowSorted1 and FlowSorted2
populations (Fig. 3a; magenta and red symbols) clustered together, while the three biological replicates of
MDA-MB-231 MDA-MB-435
Replicate versus Replicate Pearson’s r Replicate versus Replicate Pearson’s r
Parental1 Parental2 0.9960374 Parental1 Parental2 0.9996197
Parental1 Parental3 0.9965765 Parental1 Parental3 0.9999907
Parental1 Parental4 0.9893210 Parental1 Parental4 0.9999899
Parental2 Parental3 0.9972366 Parental2 Parental3 0.9995527
Parental2 Parental4 0.9951007 Parental2 Parental4 0.9996528
Parental3 Parental4 0.9954966 Parental3 Parental4 0.9999925
Selected2-1 Selected2-2 0.9879274 Selected1-1 Selected1-2 0.9999951
Selected2-1 Selected2-3 0.9949912 Selected1-1 Selected1-3 0.9999855
Selected2-2 Selected2-3 0.9924361 Selected1-1 Selected1-4 0.9999968
Selected3-1 Selected3-2 0.9979480 Selected1-2 Selected1-3 0.9999798
Selected3-1 Selected3-3 0.9968270 Selected1-2 Selected1-4 0.9999967
Selected3-2 Selected3-3 0.9974801 Selected1-3 Selected1-4 0.9999865
FlowSorted1-1 FlowSorted1-2 0.9955907 Selected2-1 Selected2-2 0.9999973
FlowSorted1-1 FlowSorted1-3 0.9969312 Selected2-1 Selected2-3 0.9999610
FlowSorted1-2 FlowSorted1-3 0.9967215 Selected2-1 Selected2-4 0.9999835
FlowSorted2-1 FlowSorted2-2 0.9874292 Selected2-2 Selected2-3 0.9999461
FlowSorted2-1 FlowSorted2-3 0.9990905 Selected2-2 Selected2-4 0.9999739
FlowSorted2-2 FlowSorted2-3 0.9913348 Selected2-3 Selected2-4 0.9999938
Table 5. Pearson’s correlation coefficient (r) values for biological replicates.
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Selected2 and Selected3 populations (Fig. 3a; orange and brown symbols) formed a separate cluster.
Similarly, three of the Parental MDA-MB-435 biological replicates (Fig. 3b; grey symbols) clustered
together and were separate from the four biological replicates of Selected1 and Selected2 populations
(Fig. 3b; orange and brown symbols). These results are consistent with the pore-selection procedure
having enriched for independent cell populations with transcriptomic profiles distinct from the
originating parental populations.
Further technical validation of the RNA-Sequencing results was provided by quantitative reverse
transcription PCR (RT-qPCR) analyses of differences in gene expression between MDA-MB-231 Parental
versus Selected (Fig. 3c) or MDA-MB-231 Selected versus FlowSorted cells (Fig. 3d) identified by RNA-
Seq. Genes were selected on the basis of fold-change, statistical significance and number of sequence
reads. The relatively higher expression of the genes encoding leukocyte immunoglobulin-like receptor
subfamily B member 1 (LILRB1), tumour necrosis factor ligand superfamily member 15 (TNFSF15),
ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), protein tyrosine phosphatase receptor
type U (PTPRU), heparin-binding epidermal growth factor (HBEGF), as well as the relatively lower
expression of matrix remodelling associated 8 (MXRA8), in Selected versus Parental (Fig. 3c) as well as in
Selected versus FlowSorted cells (Fig. 3d) were comparable in both RNA-Seq and RT-qPCR assays. In
both cases, the fold-changes determined by either method fell on a single fitted straight line with R2>0.90
and Po0.05 (Fig. 3c,d). Although the agreement between RNA-Seq and RT-qPCR was good for this
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Figure 3. Quality control of RNA-Seq data. (a) Principal component plot of RNA-Seq (DESeq2) data from
MDA-MB-231 Parental (grey symbols), Selected2 (orange symbol), Selected3 (brown symbol), FlowSorted1
(magenta symbol) and FlowSorted2 (red symbol) cell populations. Parental and FlowSorted populations
clustered distinctly from Selected populations cluster. (b) Principal component plot of RNA-Seq (DESeq2) data
from MDA-MB-435 Parental (grey symbols), Selected1 (brown symbol), and Selected2 (orange symbol) cell
populations, with the number of the biological replicate indicated within each symbol. Parental cells clustered
distinctly from the Selected populations cluster. (c) Linear regression plots of gene expression fold change
(relative to GAPDH) for Selected MDA-MB-231 cells versus Parental or (d) versus FlowSorted cells obtained by
RNA-Seq (DESeq2 data, relative to GAPDH) compared to RT-qPCR (relative to GAPDH). RNA transcripts
expressed at relatively higher levels in Selected cells: LILRB1, TNFSF15, HBEGF, PTPRU, ENPP1. RNA
transcript expressed at relatively lower levels in Selected cells: MXRA8. R2 of Goodness of Fit with P value.
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limited set of genes, it is formally possible that the analytical methods employed might have
underestimated gene expression levels15.
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